From owner-7tms_r@net.bio.net Tue Dec 05 22:00:00 1995
Path: biosci!EMBL-HEIDELBERG.DE!Gert.Vriend
From: Gert.Vriend@EMBL-HEIDELBERG.DE
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: GPCRDB server
Date: 6 Dec 1995 05:45:52 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 10
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <01HYHOA01IZI8Y4Y1Z@EMBL-Heidelberg.DE>
NNTP-Posting-Host: net.bio.net

The GPCRDB server has been updated.
In Mosaic or Netscape, use the URL
http://swift.embl-heidelberg.de/7tm/
In case something went wrong, all old data is still present under the URL:
http://swift.embl-heidelberg.de/7tm1/

Have fun, and please report problems, errors, or suggestions for improvements.

Gert.


From owner-7tms_r@net.bio.net Tue Dec 05 22:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!uwm.edu!msunews!netnews.upenn.edu!cronkite.ocis.temple.edu!astro.ocis.temple.edu!driska
From: driska@astro.ocis.temple.edu (Stephen P. Driska PhD)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Aluminum fluoride: can it cross an intact plasma membrane?
Date: 6 Dec 1995 23:17:02 GMT
Organization: Temple University, Academic Computer Services
Lines: 19
Message-ID: <4a589e$dva@cronkite.ocis.temple.edu>
NNTP-Posting-Host: astro.ocis.temple.edu
X-Newsreader: TIN [version 1.2 PL2]

	The other day I heard someone assert that (AlF4)- was 
cell-permeable and that it activated G-protein pathways by binding to
G-protein alpha subunits that were binding GDP.  The story was that because
AlF4- was similar in appearance to the phosphate ion and it somehow
mimicked the G-protein alpha subunit with GTP bound.  My question is how
would AlF4- enter intact cells ?  It seems that it would be both bulky and
negatively charged, and therefore unlikely to enter the cell readily.  
Does it utilize a phosphate transport system or just use channels or leaks
enter ?   

		Just curious.  Thanks for any ideas or references.

			Steve
--
Steve Driska, Physiology Department, Temple University Medical School
Philadelphia, PA 19140 USA (215) 707-3283 
driska@astro.ocis.temple.edu  
If I could think of something witty and clever to say, it would go right 
here ----->>    .........................

From owner-7tms_r@net.bio.net Wed Dec 06 22:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!in2.uu.net!fdn.fr!jussieu.fr!univ-lille1.fr!cresimm-pc3.univ-lille1.fr!vergoten
From: vergoten@pop.univ-lille1.fr (Gerard Vergoten)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: NATO-ASI on Biomolecular structure and dynamics"NATO Advanced Study Institute"
Date: Thu, 7 Dec 1995 10:02:25
Organization: CRESIMM - C8 - USTL - Villeneuve d'Ascq
Lines: 16
Distribution: world
Message-ID: <vergoten.3.000A0AA5@pop.univ-lille1.fr>
NNTP-Posting-Host: cresimm-pc3.univ-lille1.fr
Keywords: molecular modeling, computer simulations
X-Newsreader: Trumpet for Windows [Version 1.0 Rev A]

"BIOMOLECULAR STRUCTURE AND DYNAMICS: RECENT EXPERIMENTAL AND
THEORETICAL ADVANCES"

ASI LOUTRAKI, Greece May 27-June 6,1996

Contact: Professor G. VERGOTEN
Address: Universiti des Sciences et Technologies de Lille
         CRESIMM ( U 279 INSERM )
         UFR de Chimie  Bbt C8 - 1er itage
         59655 VILLENEUVE D'ASCQ  FRANCE
FAX    : (33) 20 33 72 79
E mail : vergoten@pop.univ-lille1.fr

Designated Publisher: KLUWER



From owner-7tms_r@net.bio.net Wed Dec 06 22:00:00 1995
Path: biosci!YALE.EDU!virginia.boundy
From: virginia.boundy@YALE.EDU ("Virginia Boundy")
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: FWD>Aluminum fluoride- can
Date: 7 Dec 1995 08:22:17 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 26
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <n1393787243.42494@QuickMail.Yale.edu>
NNTP-Posting-Host: net.bio.net

Mail*Link(r) SMTP               FWD>Aluminum fluoride: can it cross an intact
plasma...

On 12/7/95, Stephen P. Driska PhD asked about (AlF4)- mimicking the phosphate
ion...    Here are two references:

1. Bigay J, Deterre P, Pfister C, Chabre M. Fluoride complexes of aluminum or
beryllium act on G-proteins as reversibly bound analogues of the g phosphate of
GTP. EMBO J 1987; 6:2907-2913.

2. Bigay J, Deterre P, Pfister C, Chabre M. Fluoroaluminates activate
transducin-GDP by mimicking the g-phosphate of GTP in its binding site. FEBS
Lett 1985; 191:181-185.

Hope this is useful.

Virginia

---
Virginia A. Boundy, Ph.D
Molecular Psychiatry - Dept Psychiatry
Yale University
virginia.boundy@yale.edu




From owner-7tms_r@net.bio.net Wed Dec 06 22:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!elroy.jpl.nasa.gov!swrinde!newsfeed.internetmci.com!newsxfer.itd.umich.edu!news.itd.umich.edu!usenet
From: Rick Neubig <rneubig@umich.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: FWD>Aluminum fluoride- can
Date: Thu, 07 Dec 1995 22:08:39 -0500
Organization: University of Michigan
Lines: 29
Message-ID: <30C7AC37.5D2A@umich.edu>
References: <n1393787243.42494@QuickMail.Yale.edu>
NNTP-Posting-Host: pm037-06.dialip.mich.net
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 2.0b3 (Win95; I)

Virginia Boundy wrote:
> 
> On 12/7/95, Stephen P. Driska PhD asked about (AlF4)- mimicking the phosphate
> ion...    
> 2. Bigay J, Deterre P, Pfister C, Chabre M. Fluoroaluminates activate
> transducin-GDP by mimicking the g-phosphate of GTP in its binding site. FEBS
> Lett 1985; 191:181-185.
> 

There are now crystal structures of both G-alpha-i1 and transducin complexed 
with GDP and AlF4- Here's a header from the Protein Data Bank file for G 
alpha-i1

HEADER    SIGNAL TRANSDUCTION PROTEIN             11-NOV-94   1GFI      1GFI 
COMPND    GUANINE NUCLEOTIDE-BINDING PROTEIN G(I), ALPHA-1 SUBUNIT      1GFI 
COMPND   2 (G(I)-ALPHA-1) (ACTIVE FORM) COMPLEXED WITH GDP-ALF4         1GFI 
SOURCE    ORGANISM: RAT (RATTUS RATTUS); EXPRESSION SYSTEM:             1GFI 
SOURCE   2 ESCHERICHIA COLI; PLASMID: PQE6 VECTOR                       1GFI 
AUTHOR    D.E.COLEMAN,A.M.BERGHUIS,S.R.SPRANG                           1GFI 
REVDAT   2   15-MAY-95 1GFIA   1       JRNL                             
REVDAT   1   31-MAR-95 1GFI    0                                        1GFI 
JRNL        AUTH   D.E.COLEMAN,A.M.BERGHUIS,E.LEE,M.E.LINDER,           1GFI 
JRNL        AUTH 2 A.G.GILMAN,S.R.SPRANG                                1GFI 
JRNL        TITL   STRUCTURES OF ACTIVE CONFORMATIONS OF G=I ALPHA 1=   1GFI 
JRNL        TITL 2 AND THE MECHANISM OF GTP HYDROLYSIS                  
JRNL        REF    SCIENCE                       V. 265  1405 1994      1GFI 
JRNL        REFN   ASTM SCIEAS  US ISSN 0036-8075                 0038  1GFI 

Rick Neubig

From owner-7tms_r@net.bio.net Thu Dec 07 22:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!chi-news.cic.net!nntp.coast.net!swidir.switch.ch!scsing.switch.ch!news.belwue.de!fu-berlin.de!cs.tu-berlin.de!uni-erlangen.de!winx03!wpxx02.toxi.uni-wuerzburg.de!not-for-mail
From: krasel@wpxx02.toxi.uni-wuerzburg.de (Cornelius Krasel)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Sucrose monolaureate
Date: 6 Dec 1995 22:12:41 GMT
Organization: Dept. of Pharmacology, U Wuerzburg
Lines: 57
Message-ID: <4a54gp$ncj@winx03.informatik.uni-wuerzburg.de>
NNTP-Posting-Host: wpxx02.toxi.uni-wuerzburg.de
X-Newsreader: TIN [UNIX 1.3 950824BETA PL0]

I have to apologize in advance for cluttering up this newsgroup with
a private reply, but I couldn't send Steve a private reply (Microsoft
Mail bounced it); besides, it might be interesting for others as well.
Sorry.

Steve asked in private email (> > is something I posted here a few
weeks (?) ago):

> In article <48tdta$acl@winx03.informatik.uni-wuerzburg.de>, you wrote:
> > 
> > We use laurylsucrose (which is AFAIK the same) in the purification of
> > recombinant beta2-adrenergic receptors expressed in Sf9 cells. The
> > cell membranes are solubilized in laurylsucrose which is later
> > exchanged with dodecylmaltoside.
> > 
> Do you have any more details on these studies in publications?  What was
> the criteria you used in your choice of detergents (maintainence of
> binding? other?)  Why the exchange of sucrose monolaureate for
> dodecylmaltoside?  

The receptor is purified via an antagonist affinity column. For some
odd reason, the receptor solubilized in DM doesn't bind to the column
very well, so it is solubilized in LS and thus loaded on the column.
If I recall correctly, we wash then with DM and elute similarly.

I don't know if this ever has been published. You *might* be able
to find it in Kleymann et al, EJB 213 (1993), 797-804 (not by us).

> We recently put a "His-Tag" on the C-terminal of the  thrombin receptor and
> wish to isolate a photolabeled receptor.  I'm wondering if the detergent
> micells are covering up the "His-Tag" and I'm wondering about other choices
> of detergents.  

If you don't have it already, you might like to have a look at the following 
paper:

@article{janssen:95,
        author  = {Jacques J. M. Janssen and Petra H. M. Bovee-Geurts and
                   Maarten Merkx and Willem J. DeGrip},
        title   = {Histidine Tagging Both Allows Convenient Single-step
                   Purification of Bovine Rhodopsin and Exerts Ionic
                   Strength-dependent Effects on Its Photochemistry.},
        journal = JBC,
        volume  = 270,
        number  = 19,
        pages   = {11222--11229},
        year    = 1995
}

Hope that helps,

--Cornelius.

-- 
/* Cornelius Krasel, U Wuerzburg, Dept. of Pharmacology, Versbacher Str. 9 */
/* D-97078 Wuerzburg, Germany   email: phak004@rzbox.uni-wuerzburg.de  SP3 */
/* "Science is the game we play with God to find out what His rules are."  */

From owner-7tms_r@net.bio.net Thu Dec 07 22:00:00 1995
Path: biosci!ihnp4.ucsd.edu!agate!howland.reston.ans.net!nntp.coast.net!swidir.switch.ch!swsbe6.switch.ch!news.vub.ac.be!bioftp.unibas.ch!daresbury!not-for-mail
From: mcroos@imb-jena.de (Martin Roos)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: AlF4- : any lab-experiences?
Date: 8 Dec 1995 16:10:57 -0000
Lines: 41
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <4a9o2h$mrc@mserv1.dl.ac.uk>
Original-To: 7tms_r@dl.ac.uk

To enter into the discussion about the use of AlF4- in receptor research,
started by Stephen P. Driska, PhD, 12/7/95:

Concerning the beta-adrenergic receptor, it is already textbook
knowledge, that an Gsalpha in the "on" form reduces the affinity of the
receptor for its hormon ligand.

I wonder:
1. if this principle can be applied as well for other G-protein coupled
receptors.

2. if this principle could be applied for isolating receptor, ex vivo,
with low amount of endogenous ligand bound to the receptor.

I am working with endothelin-receptors, where once bound endothelin is
nearly undissociable. This fact impares the yield of affinity-purified
receptor, using endothelin as ligand.
Instead of expensive GTP I have been thinking about AlF4- to be the
molecule keeping the G-Protein "on".

Any comments, suggestions?

Martin
________________________________________________
Martin Roos, PhD-student
Institut fuer Molekulare Biotechnologie e.V
Proteinlabor
Beutenbergstr. 11
D-07745 Jena
Germany

e-mail: mcroos@imb-jena.de
fax: ++49-3641-656225
tel: ++49-3641-656263
__________________________________________________________







From owner-7tms_r@net.bio.net Fri Dec 08 22:00:00 1995
Path: biosci!ihnp4.ucsd.edu!news.service.uci.edu!usenet
From: Rob Steele <resteele@uci.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: (no subject)
Date: 8 Dec 1995 23:31:08 GMT
Organization: University of California, Irvine
Lines: 11
Message-ID: <4aahrs$haj@news.service.uci.edu>
NNTP-Posting-Host: xenopus.biochem.uci.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Macintosh; I; 68K)
X-URL: news:bionet.molbio.proteins.7tms_r

We are studying development of the cnidarian Hydra.  In the process of 
cloning homeobox genes from this animal we have recently identified a 
homologue of PAX-6, a paired-type gene involved in eye development in 
flies and mammals.  Since cnidarians have primitive eyes, we have become 
interested in the possibility of identifying an opsin gene in Hydra.  Is 
anyone aware of a successful PCR approach for specifically cloning 
members of the opsin subfamily of 7TM receptors?  If so, could you send 
me the reference (if it has been published) or details on the method if 
it hasn't yet been published.  Thanks for your help.



From owner-7tms_r@net.bio.net Sun Dec 10 22:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!btnet!demon!cityscape.co.uk!usenet
From: ae55@cityscape.co.uk (John Bates)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Protein-Bound NSAID problem
Date: 11 Dec 1995 13:48:01 GMT
Organization: IP-GOLD User
Lines: 12
Message-ID: <4ahcqh$18b@news.cityscape.co.uk>
NNTP-Posting-Host: cisae55.demon.co.uk
X-Newsreader: WinVN 0.92.6+

Several of the NSAID drugs are very hydrophobic and readily bind to hydrophobic
sites on certain plasma proteins, particularly albumin. This is creating a problem for a
flurbiprofen/ibuprofen plasma extraction technique I am using. Any suggestion on how
these drugs can be released from these sites. I don't want to use an organic such as
methanol.

I have used the conventional liquid-liquid and solid phase techniques successfully and
in fact they are very simple. The specialised technique I am using however is somewhat
different and requires that I "release" the two NSAIDs before extraction.

John


From owner-7tms_r@net.bio.net Sun Dec 10 22:00:00 1995
Path: biosci!FARMR1.MED.UTH.TMC.EDU!aschonb
From: aschonb@FARMR1.MED.UTH.TMC.EDU (A. Schonbrunn)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: PTX sensitive G proteins
Date: 11 Dec 1995 07:34:30 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 14
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <v02130500acf1ff1b30df@[129.106.28.19]>
NNTP-Posting-Host: net.bio.net

I would appreciate recommendations for review articles summarizing
differences/similarities in the biochemical and signalling properties of
the pertussis toxin sensitive G proteins.
Thanks in advance.



**************************************************************************
Agi Schonbrunn, Ph.D.              e-mail: aschonb@farmr1.med.uth.tmc.edu
Dept. of Pharmacology,
Univ. of Texas Medical School
P.O.Box 20708, Houston,TX 77225



From owner-7tms_r@net.bio.net Mon Dec 11 22:00:00 1995
Path: biosci!internet!biosci!not-for-mail
From: biohelp (BIOSCI Administrator)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: IMPORTANT: BIOSCI miniFAQ
Date: 12 Dec 1995 02:01:18 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 202
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199512121000.CAA07523@net.bio.net>
NNTP-Posting-Host: net.bio.net

(LAST REVISION: 08-DEC-95)

This is a new "miniFAQ" designed to answer the questions that come up
the *most frequently*.  The main BIOSCI FAQ (Frequently Asked
Questions) is accessible on the World Wide Web at URL
http://www.bio.net/.

	Contents:
	--------
	1) What to do about "spams," i.e., junk mail, ads, etc.

	2) Examples of subscribing and unsubscribing to the mailing lists.

	3) How to access BIOSCI/bionet newsgroup archives.

	4) The BIOSCI user address and research interest directory.


1) What to do about "spams," i.e., junk mail, ads, etc.
-------------------------------------------------------
BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups)
and mailing lists.  The same postings are distributed on both media
(except for a small number of mailing-list-only groups at
net.bio.net).  Unfortunately it is becoming a despicable practice on
the Internet (by a few people out to make a fast buck) to do automated
mass postings to thousands of newsgroups and mailing lists.  These
attempts to grab free advertising are refered to as "spams" in the
usual, somewhat boneheaded, net terminology.  USENET is more
susceptible to this practice, and many spams originate on the USENET
groups and then are passed on to the mailing lists.  However, spammers
also get lists of mailing addresses and hit these too, so neither
medium is immune.

What should you do personally if you get junk mail?
---------------------------------------------------
Just delete it and move on without reading it further.  Filing a
protest is becoming increasingly useless because spammers are often
disguising the addresses where the messages are sent from.  Unless you
really understand Internet mail systems, your attempt at protest by
sending replies to the message will often end up being sent to the
address of an innocent person that the spammer is victimizing.

What can BIOSCI/bionet do to protect its newsgroups?
----------------------------------------------------
The only solution currently available is to moderate the newsgroup.
If this newsgroup is already moderated, then you are in good shape.
Moderation protects the USENET distribution from about 95% of the
spams that are being sent to date and protects the mailing lists
completely.  Moderation means, however, that someone has to take the
time to review each message before it goes out.  We have set up
software here that simply allows the moderator to forward to an
address at net.bio.net messages that (s)he wishes to have distributed.
This takes no more time than that needed to read the message and pass
it on, say about 1 min. per message.

Most newsgroups currently have a discussion leader who is responsible
for their newsgroup.  The discussions leaders and their e-mail
addresses are listed in the BIOSCI Information Sheet which is
available on the Web at http://www.bio.net/.  If a newsgroup is being
hit with too many junk postings, please contact the discussion leader
for that group and see if there is interest in moderating the group.
Please do not assume that by simply posting a complaint to the
newsgroup itself, anyone on the BIOSCI staff will act on your
complaint.  With close to 100 newsgroups to run, the BIOSCI staff has
to rely on the discussion leaders of each newsgroup to report problems
directly to us at biosci-help@net.bio.net.

We will moderate any of our newsgroups if the discussion leader tells
us that the readership of the group wishes to do so and if a moderator
is willing to do the work.  For most BIOSCI/bionet groups, this
entails only a few minutes of work each day.

Moderating a newsgroup will resolve probably 95% of the junk postings
on the USENET distribution.  Unfortunately there are easy ways for
determined spammers to override the moderation mechanism on USENET,
but we can protect our e-mail subscribers from unwanted postings if
the newsgroup is moderated.  We are working on new systems to provide
access to our newsgroups over the WWW.  These will be available by 11
December 1995 and will allow you to use your Web browser to look at
the news postings via our Web site at URL http://www.bio.net.  While
this Web interface will not stop spammers from trying to post to the
groups, this will give you yet another way, besides using USENET news,
to keep the junk out of your personal mail files.  For those of you
with local USENET news systems, the Web interface will also give you
faster access to new newsgroups and recent postings.


2) Examples of subscribing and unsubscribing to the mailing lists.
------------------------------------------------------------------
PLEASE NOTE: The BIOSCI management does NOT act on
subscription/unsubscription requests that are posted improperly to the
newsgroups and mailing lists.  People who do this only bother everyone
on the lists to no avail.  Please be sure to follow the proper
procedures below.

Gory details are in the BIOSCI Information sheets on the Web at
http://www.bio.net.  Below we give an example utilizing the
METHODS-AND-REAGENTS list at both of our two BIOSCI sites:

Users in the Americas and Pacific Rim countries who use the BIOSCI
------------------------------------------------------------------
node at computer net.bio.net:
----------------------------

A) Determine the "listname" which is the <=8 character mail address
                                         ^^^^^^^^^^^^^
   for the group.  These can be found in the BIOSCI Info. Sheet.  For
   the METHODS-AND-REAGENTS group the mailing address is
   methods@net.bio.net.  The listname is the portion of the address to
   the left of the @ sign, i.e., "methods".  The listname is used with
   the "subscribe" and "unsubscribe" commands illustrated below.

B) Mail all commands in the body of a mail message addressed to
   biosci-server@net.bio.net.  Do NOT send commands to the newsgroup
   posting addresses!  Leave the Subject: line blank, any text on it
   will be ignored.

C) In the body of your message put one or more of the following
   commands with an "end" command on the last line, e.g.,

   subscribe methods
   unsubscribe methods
   end

   Do NOT put your e-mail address or other text on these lines.  The
   server only allows you to cancel your subscription if the address
   on your mail header matches the address on our mailing list.
   Please ask for help at biosci-help@net.bio.net if your address has
   changed, e.g., if you know you are on the list but the server tells
   you that you are not a member.


Users in Europe, Africa, and Central Asia who use the BIOSCI node at
--------------------------------------------------------------------
computer daresbury.ac.uk (also known as dl.ac.uk):
-------------------------------------------------

To subscribe and unsubscribe to/from the BIOSCI lists, you need to
specify the full USENET newsgroup name with "bionet-news." prepended.
The USENET newsgroup names are listed in the BIOSCI Information sheet
on the Web at http://www.bio.net/.  For the METHODS-AND-REAGENTS list
the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the
appropriate commands are

    sub bionet-news.bionet.molbio.methds-reagnts

    unsub bionet-news.bionet.molbio.methds-reagnts

These commands are included in a message addressed to mxt@dl.ac.uk,
NOT to the newsgroup mailing addresses.  As usual, include the text in
the body of the message as text on the Subject: line is ignored.

To unsubscribe from all the lists at the UK node, use

    unsub bionet-news

Please note that if the address in the list is different than the one
in your mail message header, you will not be able to unsubscribe by
this method. If you have problems, please mail biosci@daresbury.ac.uk.


3) How to access BIOSCI/bionet newsgroup archives.
--------------------------------------------------
Back postings of all BIOSCI/bionet newsgroups can be found on the
World Wide Web at URL http://www.bio.net/.  There are several
searchable newsgroup indices at this site.  E-mail users can search
the BIOSCI archives by using our waismail e-mail server.  For
instructions send the message

help

to waismail@net.bio.net.  Leave the Subject: line blank (anything
entered on the Subject: line is ignored).


4) The BIOSCI user address and research interest directory.
-----------------------------------------------------------
Please take this opportunity to add your name, address, and research
interest information to the BIOSCI User Address Database if you have
not already done so.

You can fill out the address form directly through our Web page at URL
http://www.bio.net/adrform.html.

The address database is reindexed nightly for WWW access (the URL is
http://www.bio.net/).  If you are not directly on the Internet but can
reach it by e-mail, please use our waismail server to access the user
directory.  waismail use is described above.  You can also request a
user address form by e-mail from biosci-help@net.bio.net.

Please check your database entry from time-to-time to see if your
address information is still up-to-date.  Because of our limited
personnel resources, we ask that you resubmit a *complete* form to
revise your entry; we only replace complete entries and do not have
resources to edit old forms.

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				biosci-help@net.bio.net

From owner-7tms_r@net.bio.net Mon Dec 11 22:00:00 1995
Path: biosci!sci.himeji-tech.ac.jp!yagisawa
From: yagisawa@sci.himeji-tech.ac.jp (YAGISAWA, Hitoshi)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Subscription
Date: 12 Dec 1995 03:12:37 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 13
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199512121116.UAA27931@perm.sci.himeji-tech.ac.jp>
NNTP-Posting-Host: net.bio.net

Subscribe Hitoshi YAGISAWA
--------------------------------
        Hitoshi YAGISAWA, Ph.D

Laboratory of Biological Signalling
      Department of Life Science
   Himeji Institute of Technology
     Harima Science Garden City
          Hyogo, 678-12 JAPAN
         Tel: +81-7915-8-0204
         Fax: +81-7915-8-0197
-------------------------------


From owner-7tms_r@net.bio.net Tue Dec 12 22:00:00 1995
Path: biosci!PO.CWRU.EDU!pre
From: pre@PO.CWRU.EDU
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: AlF4- : any lab-experiences?
Date: 13 Dec 1995 07:00:33 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 21
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199512131458.JAA02805@slc5.INS.CWRU.Edu>
NNTP-Posting-Host: net.bio.net


> To enter into the discussion about the use of AlF4- in receptor research,
> started by Stephen P. Driska, PhD, 12/7/95:
> 
> I am working with endothelin-receptors, where once bound endothelin is
> nearly undissociable. This fact impares the yield of affinity-purified
> receptor, using endothelin as ligand.
> Instead of expensive GTP I have been thinking about AlF4- to be the
> molecule keeping the G-Protein "on".
> 
Endothelin binding is not entirely G-protein dependent.  Have you tried
eluting with an alkaline buffer?  Endothelin binding is highly pH-sensitive.
Also, DTT will denature endothelin owing to the critical disulfide bridges
without harming the receptor.


-- 
Paul Ernsberger, PhD, Associate Prof. of Medicine, Pharmacology & Neuroscience
Case Western Reserve University, Cleveland, OH 44106-4982  FAX: (216)368-4752
Address all e-mail to: pre@po.cwru.edu *+*+*+*+*+*+*+*+*+*+*+*+*+*+*+*+*+*+*+*


From owner-7tms_r@net.bio.net Thu Dec 14 22:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!howland.reston.ans.net!newsserver.jvnc.net!synapse.bms.com!pawlowski.bms.com!user
From: pawlowski@bms.com (John Pawlowski)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Largest GPCR agonists?
Date: 15 Dec 1995 21:04:24 GMT
Organization: BMS
Lines: 13
Message-ID: <pawlowski-1512951736280001@pawlowski.bms.com>
NNTP-Posting-Host: pawlowski.bms.com

Having recently attended a conference on GPCRs which was heavily devoted
to ligand recognition, structure/function relationships and modeling, I
was wondering about the differences in ligands of GPCRs versus ligands of
tyrosine kinase receptors. In particular, the peptide ligands of GPCRs are
quite small, whereas TKR agonists are generally >10 kDa. I was wondering
if anyone could tell me what is the largest GPCR ligand (thrombin doesn't
count), and what are the smallest activators of TKRs? Thanks much.

John

-- 
John Pawlowski
pawlowski@bms.com

From owner-7tms_r@net.bio.net Thu Dec 14 22:00:00 1995
Newsgroups: bionet.molbio.proteins.7tms_r
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!in1.uu.net!nih-csl!helix.nih.gov!dewolf
From: "A.M. van Rhee" <dewolf@helix.nih.gov>
Subject: GPCR database
Content-Type: TEXT/PLAIN; charset=US-ASCII
Message-ID: <Pine.SGI.3.91.951215122543.18291E-100000@helix.nih.gov>
Sender: postman@alw.nih.gov (AMDS Postmaster)
Nntp-Posting-Host: helix.nih.gov
Organization: National Institutes of Health
Mime-Version: 1.0
Date: Fri, 15 Dec 1995 17:27:58 GMT
Lines: 26


Oops,

sorry about that. I apparently forgot that some browsers are very 
sensitive to the exact syntax of the URL. The URL should be:

http://mgddk1.niddk.nih.gov:8000/GPCR.html

and don't use a trailing / (that leads to the source text and won't have 
active links).

Sorry again,

  Michael.


Dr. A.M. van Rhee
National Institutes of Health
National Institute of Diabetes, Digestive and Kidney Diseases
Laboratory of Bioorganic Chemistry - Molecular Recognition Section
Bldg. 8A  Rm. B1A17
Bethesda, Maryland 20892-0810
tel: (301) 435-1936 // fax: (301) 402-4182 // dewolf@helix.nih.gov
URL: http://mgddk1.niddk.nih.gov:8000/



From owner-7tms_r@net.bio.net Thu Dec 14 22:00:00 1995
Newsgroups: bionet.molbio.proteins.7tms_r
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!in2.uu.net!nih-csl!helix.nih.gov!dewolf
From: "A.M. van Rhee" <dewolf@helix.nih.gov>
Subject: GPCR Mutant Database
Content-Type: TEXT/PLAIN; charset=US-ASCII
Message-ID: <Pine.SGI.3.91.951215081848.18291A-100000@helix.nih.gov>
Sender: postman@alw.nih.gov (AMDS Postmaster)
Nntp-Posting-Host: helix.nih.gov
Organization: National Institutes of Health
Mime-Version: 1.0
Date: Fri, 15 Dec 1995 13:29:55 GMT
Lines: 41


Hello all.

A short while ago I posted something about a mutant GPCR database that 
we're working on here at NIH.

Because of high demand, we've speeded up the process of conversion to 
HTML and we now have a part of our database on-line.

The way it's set-up is not ideal (not even for our own standards), but it 
will allow you to find out more about mutants in the transmembrane 
domains of family A/rhodopsin related GPCRs.

Since it's all very experimental, we'd really appreciate comments and 
contributions from the GPCR community at large.

We've been talking to Frank Kolakowski (GCRdB) and Gert Vriend (EMBL) to 
set up a common site/framework for this kind of database, but I'd really 
like to get some input from other people. Besides, I think a common 
project would take at least half a year to get started, and I don't want 
to keep everyone in suspense.

You can access the database through URL:

http://mgddk1.niddk.nih.gov:8000/GPCR.html/

Have fun with it, and hope to hear from you soon.

  Michael.


Dr. A.M. van Rhee
National Institutes of Health
National Institute of Diabetes, Digestive and Kidney Diseases
Laboratory of Bioorganic Chemistry - Molecular Recognition Section
Bldg. 8A  Rm. B1A17
Bethesda, Maryland 20892-0810
tel: (301) 435-1936 // fax: (301) 402-4182 // dewolf@helix.nih.gov
URL: http://mgddk1.niddk.nih.gov:8000/



From owner-7tms_r@net.bio.net Fri Dec 15 22:00:00 1995
Path: biosci!agate!howland.reston.ans.net!swrinde!cssun.mathcs.emory.edu!emory!news.cc.emory.edu!usenet
From: medtjm@bimcore.emory.edu (T. J. Murphy)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Largest GPCR agonists?
Date: 16 Dec 1995 21:42:49 GMT
Organization: Biomolecular Computing Resource, Emory University
Lines: 15
Distribution: world
Message-ID: <4avegp$sgq@moe.cc.emory.edu>
References: <pawlowski-1512951736280001@pawlowski.bms.com>
Reply-To: medtjm@bimcore.emory.edu
NNTP-Posting-Host: bimcore.emory.edu

In article 1512951736280001@pawlowski.bms.com, pawlowski@bms.com (John Pawlowski) writes:
>..... I was wondering
>if anyone could tell me what is the largest GPCR ligand (thrombin doesn't
>count), and what are the smallest activators of TKRs? Thanks much.
>


You didn't ask, but my favorite smallest activator of a GPCR is the photon!
---
TJ Murphy
Asst. Professor	      
Dept of Pharmacology
Emory University School of Medicine   	    



From owner-7tms_r@net.bio.net Sat Dec 16 22:00:00 1995
Path: biosci!VAX.GRC.NIA.NIH.GOV!chahrzad
From: chahrzad@VAX.GRC.NIA.NIH.GOV
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Gi-linked receptor
Date: 17 Dec 1995 11:42:35 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 7
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <0099B016.226A989A.12@vax.grc.nia.nih.gov>
NNTP-Posting-Host: net.bio.net

Could anyone help me clarify this issue for me? I have a peptide that in. could
some tissues lowers cAMP but via a pertussis toxin insensitive manner! How
could this be? Please let me know if you have any information on similar
situations with other peptides or hormones and please let me know of elase
already published data (if available). Thank you!
Chahrzad Montroseo
Email: Chahrzad@vax.grc.nia.nih.govrhr

From owner-7tms_r@net.bio.net Sun Dec 17 22:00:00 1995
Path: biosci!novo.dk!khou
From: khou@novo.dk (Khaled M. Houamed)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Largest GPCR agonists?
Date: 18 Dec 1995 12:23:52 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 17
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <v01510100acfb7d4529e8@[152.73.96.129]>
NNTP-Posting-Host: net.bio.net

>Having recently attended a conference on GPCRs which was heavily devoted
>to ligand recognition, structure/function relationships and modeling, I
>was wondering about the differences in ligands of GPCRs versus ligands of
>tyrosine kinase receptors. In particular, the peptide ligands of GPCRs are
>quite small, whereas TKR agonists are generally >10 kDa. I was wondering
>if anyone could tell me what is the largest GPCR ligand (thrombin doesn't
>count), and what are the smallest activators of TKRs? Thanks much.
>
>John
>
>--
>John Pawlowski
>pawlowski@bms.com

The glycoprotein hormones LH, FSH, TSH are > 20 kilo-dalton



From owner-7tms_r@net.bio.net Sun Dec 17 22:00:00 1995
Path: biosci!CTS.COM!Kinta
From: Kinta@CTS.COM
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Detection of intracellular cAML levels
Date: 18 Dec 1995 14:43:25 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 10
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <m0tRoFY-000UzcC@mailhub.cts.com>
NNTP-Posting-Host: net.bio.net

Dear Netter:

Dose anyone know the methods for direct detection of intracelluar cAMP levels?
I'm looking for the technique to visualize (color or fluorescence etc.) the
intracellular cAMP levels.

Any help would be appreciated.

S. Kaneta


From owner-7tms_r@net.bio.net Sun Dec 17 22:00:00 1995
Path: biosci!PINK.INCM.U-NANCY.FR!campagne
From: campagne@PINK.INCM.U-NANCY.FR (Fabien Campagne)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: HELP
Date: 18 Dec 1995 02:26:52 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 8
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.SGI.3.91.951218112415.29686A@pink.incm.u-nancy.fr>
NNTP-Posting-Host: net.bio.net




Fabien Campagne -- campagne@pink.incm.u-nancy.fr | Theoretical Chemistry Dept.
phone: (033) 83 91 20 00 extension 3236          | University of Nancy, France.




From owner-7tms_r@net.bio.net Sun Dec 17 22:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!usenet.eel.ufl.edu!clas.ufl.edu!usenet.ufl.edu!receptor.pharmacology.ufl.edu!user
From: jharrison@qm.server.ufl.edu (Jeffrey K. Harrison)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Largest GPCR agonists?
Followup-To: bionet.molbio.proteins.7tms_r
Date: Mon, 18 Dec 1995 10:18:15 -0500
Organization: University of Florida
Lines: 11
Message-ID: <jharrison-181295101815@receptor.pharmacology.ufl.edu>
References: <pawlowski-1512951736280001@pawlowski.bms.com>
NNTP-Posting-Host: receptor.pharmacology.ufl.edu


How about chemoattractant cytokines (chemokines)?  Not sure if they are the
largest, but they are probably near the top of the list.  These ligands are
70-80 amino acids in length, and about 8-10 kDa in size.  Some of the
rodent orthologs are even larger, e.g. murine/rat MCP-1, weighing in around
14 kDa.


Jeffrey K. Harrison, Ph.D.
Assistant Professor of Pharmacology and Therapeutics
University of Florida

From owner-7tms_r@net.bio.net Mon Dec 18 22:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!newsxfer.itd.umich.edu!news.itd.umich.edu!usenet
From: Rick Neubig <RNeubig@umich.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Detection of intracellular cAML levels
Date: Tue, 19 Dec 1995 10:40:36 -0500
Organization: University of Michigan
Lines: 36
Message-ID: <30D6DCF4.12C1@umich.edu>
References: <m0tRoFY-000UzcC@mailhub.cts.com>
NNTP-Posting-Host: warbler.med.umich.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 2.0b3 (Win95; I)

Kinta@CTS.COM wrote:
> 
> Dear Netter:
> 
> Dose anyone know the methods for direct detection of intracelluar cAMP levels?
> I'm looking for the technique to visualize (color or fluorescence etc.) the
> intracellular cAMP levels.

Tsien and Taylor published a method based on energy transfer between 
the regulatory and catalytic subunits of PKA. I'm not sure how easy this 
is but check the following references. (I seem to recall seeing a 
commercial advertisement for reagents for this method).

TI: 	Imaging of cAMP signals and A-kinase translocation in single 
living cells.
AU: 	Adams-S; Bacskai-B; Harootunian-AT; Mahaut-Smith-M; Sammak-PJ; 
Taylor-SS; Tsien-RY
SO: 	Adv-Second-Messenger-Phosphoprotein-Res. 1993; 28: 167-70

TI: 	Fluorescence ratio imaging of cyclic AMP in single cells.
AU: 	Adams-SR; Harootunian-AT; Buechler-YJ; Taylor-SS; Tsien-RY
SO: 	Nature. 1991 Feb 21; 349(6311): 694-7

Rick

> 
> Any help would be appreciated.
> 
> S. Kaneta

-- 

_________________________________________________________
Rick Neubig                             RNeubig@umich.edu
University of Michigan               Phone (313) 763-3650
http://www.umich.edu/~rneubig        FAX   (313) 763-4450

From owner-7tms_r@net.bio.net Tue Dec 19 22:00:00 1995
Path: biosci!BIO.VU.NL!hind
From: hind@BIO.VU.NL (Hind van Tol-Steye)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: intracellular cAMP levels
Date: 20 Dec 1995 07:39:34 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 32
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9512201537.AA00749@bio.vu.nl>
NNTP-Posting-Host: net.bio.net

Dose anyone know the methods for direct detection of intracelluar cAMP levels?
> I'm looking for the technique to visualize (color or fluorescence etc.) the
> intracellular cAMP levels.

Tsien and Taylor published a method based on energy transfer between 
the regulatory and catalytic subunits of PKA. I'm not sure how easy this 
is but check the following references. (I seem to recall seeing a 
commercial advertisement for reagents for this method).

TI:     Imaging of cAMP signals and A-kinase translocation in single 
living cells.
AU:     Adams-S; Bacskai-B; Harootunian-AT; Mahaut-Smith-M; Sammak-PJ; 
Taylor-SS; Tsien-RY
SO:     Adv-Second-Messenger-Phosphoprotein-Res. 1993; 28: 167-70

TI:     Fluorescence ratio imaging of cyclic AMP in single cells.
AU:     Adams-SR; Harootunian-AT; Buechler-YJ; Taylor-SS; Tsien-RY
SO:     Nature. 1991 Feb 21; 349(6311): 694-7

Rick

> 
> Any help would be appreciated.
> 
> S. Kaneta


The cAMP fluorosensor developped by Tsien and Taylor is commercially
available from Atto instruments, 1450 research boulevard rockville MD 20850
301 340 7320 FAX 301 340 9775, email sales@atto.com. Price is $695.00 for
10 microl of 10-15 microM ready for micro-injection.


From owner-7tms_r@net.bio.net Tue Dec 19 22:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!newsxfer2.itd.umich.edu!newsxfer.itd.umich.edu!news.itd.umich.edu!usenet
From: Rick Neubig <RNeubig@umich.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: intracellular cAMP levels
Date: Wed, 20 Dec 1995 12:51:34 -0500
Organization: University of Michigan
Lines: 14
Message-ID: <30D84D26.3CB5@umich.edu>
References: <9512201537.AA00749@bio.vu.nl>
NNTP-Posting-Host: warbler.med.umich.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 2.0b3 (Win95; I)

Hind van Tol-Steye wrote:
> 
> The cAMP fluorosensor developped by Tsien and Taylor is commercially
> available from Atto instruments, 1450 research boulevard rockville MD 20850
> 301 340 7320 FAX 301 340 9775, email sales@atto.com. Price is $695.00 for
> 10 microl of 10-15 microM ready for micro-injection.

So have you used it and does it work well?
Rick 

_________________________________________________________
Rick Neubig                             RNeubig@umich.edu
University of Michigan               Phone (313) 763-3650
http://www.umich.edu/~rneubig        FAX   (313) 763-4450

From owner-7tms_r@net.bio.net Wed Dec 20 22:00:00 1995
Path: biosci!BIO.VU.NL!hind
From: hind@BIO.VU.NL (Hind van Tol-Steye)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: cAMP fluorosensor
Date: 21 Dec 1995 06:51:05 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 5
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9512211449.AA00324@bio.vu.nl>
NNTP-Posting-Host: net.bio.net

About the cAMP fluorosensor: I have not used it; we have no equipment to
measure emmission ratio's.

Hind.


From owner-7tms_r@net.bio.net Tue Dec 26 22:00:00 1995
Path: biosci!agate!overload.lbl.gov!news.kreonet.re.kr!news.dacom.co.kr!news.uoregon.edu!news.orst.edu!Schimerlik2-2131-E.ALS.ORST.EDU!bulsecod
From: bulsecod@labtalk.als.orst.edu (Lab)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: global curve fitting
Date: Wed, 27 Dec 1995 10:05:47
Organization: University Computing Services - Oregon State University
Lines: 16
Message-ID: <bulsecod.117.000A1905@labtalk.als.orst.edu>
NNTP-Posting-Host: schimerlik2-2131-e.als.orst.edu
X-Newsreader: Trumpet for Windows [Version 1.0 Rev A]


Has anyone used the latest version of Origin (4.0) for non-linear curve 
fitting? It has 'global' fitting built in (in the sense that you can set it to 
share parameters across multiple data sets).  I am trying to implement this 
global fitting using different equations, and have not had much success.  
Anyone out there been able to do this? 

Also, have you been able to implement 'global fitting' in any other packages 
besides Scientist and SigmaPlot (and Origin)?

Thanks...


Dylan

bulsecod@labtalk.als.orst.edu

From owner-7tms_r@net.bio.net Wed Dec 27 22:00:00 1995
Path: biosci!LYNX.DAC.NEU.EDU!pwick
From: pwick@LYNX.DAC.NEU.EDU (peter f wick)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: (none)
Date: 28 Dec 1995 13:26:10 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 1
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199512282124.QAA28523@lynx.dac.neu.edu>
NNTP-Posting-Host: net.bio.net

subscribe pwick@lynx.neu.edu 7TMS_r@net.bio.net

